Bryan Krastins
Papers
1
Total Citations
52
H-Index
1
About
Bryan Krastins has established himself as a leading figure in the field of clinical mass spectrometry and proteomics, with a particular focus on developing high-throughput, quantitative assays for protein biomarkers. His most notable work centers on the measurement of insulin-like growth factor 1 (IGF1), a critical biomarker for managing growth hormone disorders. Krastins pioneered a groundbreaking parallel workflow for high-throughput quantitative analysis of IGF1 using mass spectrometric immunoassay, enabling processing of over 1,000 samples per day—a dramatic improvement over traditional methods. This work, cited 52 times, addresses the pressing need for clinically viable MS-based assays by overcoming key barriers to widespread adoption. Beyond IGF1, Krastins has made significant contributions to the development of robust, reproducible proteomic workflows that bridge the gap between research and clinical diagnostics. His efforts have been instrumental in demonstrating that mass spectrometry can achieve the throughput, sensitivity, and reliability required for routine clinical use, positioning him as a key innovator in translational proteomics and biomarker validation.
Research Focus
Key Achievements
Top Papers
- 1